Alain CornetAt the recent American Congress of Rheumatology in San Fransisco this week, we received fantastic news on two promising trial results. 1. AstraZeneca Phase IIb Anifrolumab 300 mg showed positive results, where it produced a response in 34.4 percent of patients after 169 days of treatment and this rose to more than 50 percent after […]
Alain CornetThis is just a reminder that the December deadline for patient stories is fast approaching. If you are a member of one of our patient organisations and want to share your story please send it to katharine@lupus-europe.org
Alain CornetEPF is launching a second consultation on a draft position on defining and measuring access to healthcare. The position paper was developed with the working group on access. The first consultation was held in September/October. Lupus Europe is involved in this working group and your input to the consultation would be much appreciated if you […]
🦋 According to our "Living with Lupus in 2020" survey, UV sensitivity ranks among the most common and bothersome symptoms for those living with #lupus.
🔊 Join us! Share how this facet of #SLE limits your daily activities and the strategies you use to #KickLupus and UV light
✅ Very happy to report that we have completed the entiere STEP1 of #ENDORSED, the international #consensus definition of #SEVERE #LUPUS by the #DORIS group gathering 50+ potential facets of severity thanks to the international panel of HCPs (step 1a) and patients (step 1b) 👍
✅ Using #ChatGPT to generate a POST-#EULAR2025 summary about #Lupus ⬇️ how did I do that?!? I performed a search for 'lupus' in the online program of the congress🔎 copy-pasted the results in chatGPT and used it to perform a 'thematic analysis' on the results 💪👍 FASCINATING
🌟Thank you to all who attended our #EULAR2025 debrief webinar!
🙌 Especially to our presenters, volunteers & PAN members who shared their insights & experiences.
Stay tuned for more news and updates & don't forget to subscribe to our newsletter! https://www.lupus-europe.org/emails/
On #ChronicDiseaseDay, our #3TR patient representatives shared what keeps them going: their families, their friends, and the patient communities they’re part of. 💪❤️
👇 Tell us: who do you stay strong for?
#ChronicDiseaseDay #Lupus #MS #Asthma
⏰ Just 1 hour left for our #EULAR2025 highlights webinar!
😨 You haven't registered yet? Don't worry! We have🔝news for you!
✅ You can still catch all the insights live on our Facebook page https://f.mtr.cool/rfbzgadqse
Join us at 18h CET to explore 🗝️ takeaways from the Congress!
🔊Listen to the #eularPARE podcast, "Working with an RMD: Real Stories, Real Strategies".
🎙️Hear inspiring guests share practical tips for managing work life while living with an RMD.
Join here:
Spotify: https://pulse.ly/mo14plakig
Apple: https://pulse.ly/ceantfnfwd
#Rheumatology
🌟Our #EULAR2025 highlights webinar is tomorrow!
👨⚕️Some of the presenters will share the main takeaways from their talks.
🦋Also, some of our volunteers will share their insights from the Congress.
Don’t miss this opportunity!
Register now by ✉️ secretariat@lupus-europe.org
😨 Did you miss our #EULAR2025 debrief webinar?
😮💨 Don't worry! You can watch the full session at your convenience.
Catch up on all the insights shared by many of the presenters, as well as some of our volunteers and PAN members, on our Facebook page!
www.facebook.com/LupusEurope/videos/1257813502412444
0 CommentsComment on Facebook
‼️ According to our "Living with Lupus in 2020" survey, 𝐔𝐕 𝐬𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐢𝐭𝐲 𝐫𝐚𝐧𝐤𝐬 𝐚𝐦𝐨𝐧𝐠 𝐭𝐡𝐞 𝐦𝐨𝐬𝐭 𝐜𝐨𝐦𝐦𝐨𝐧 𝐚𝐧𝐝 𝐛𝐨𝐭𝐡𝐞𝐫𝐬𝐨𝐦𝐞 𝐬𝐲𝐦𝐩𝐭𝐨𝐦𝐬 for those with lupus.
😱 In fact, 𝟔𝟖.𝟓% of respondents reported experiencing sun sensitivity, making it a significant concern for many.
💥 UV sensitivity can greatly limit daily activities and impact the quality of life for people with lupus. Here are a few examples:
🏗️ 𝐎𝐮𝐭𝐝𝐨𝐨𝐫 𝐣𝐨𝐛𝐬: Those who work outdoors, such as in construction, agriculture, or any job requiring prolonged sun exposure, often struggle to manage their symptoms.
The need to stay covered and protected from the sun can make these jobs particularly challenging.
🏖️ 𝐅𝐚𝐦𝐢𝐥𝐲 𝐚𝐧𝐝 𝐬𝐨𝐜𝐢𝐚𝐥 𝐥𝐢𝐟𝐞: UV light can significantly impact social and family life for individuals with lupus.
Activities such as spending a day at the beach, attending park outings, enjoying barbecues, and participating in festivals or outdoor events become challenging due to the need for constant sun protection.
This often means seeking shade, wearing protective clothing, and applying sunscreen regularly, which can limit spontaneity and enjoyment.
For some patients, the sensitivity to UV light is so severe that they cannot attend these events at all, as exposure could trigger a lupus flare, further limiting their ability to engage in social and family activities.
🔊 Join us this month as we share tips and strategies to manage UV sensitivity and protect yourself from the sun.
😊 Share your experiences and how you #KickLupus & UV light in your daily life
0 CommentsComment on Facebook
🟣 Phase 2 of LUPUS-ALERT is now complete!
Thanks to the incredible contributions of patients and healthcare professionals from around the world, we are one step closer to creating a tool that will screen for vulnerabilities people may face during lupus care.
🔍 LUPUS-ALERT is a project co-developed by patients and clinicians that will systematically screen for vulnerabilities that can impact lupus management:
🔷 Associated conditions
🔷 Comorbidities
🔷 Social and economic context
🔷 Challenges and barriers — like language, access to medication, or distance to care
🙌 Thank you to everyone who has helped shape this project so far. Your input is helping shape a more equitable and person-centred future for lupus care.
💜 A very special thank you to Prof Laurent Arnaud and Dr Guimarães de Oliveira for their commitment and dedication throughout this process!
📌 Stay tuned — more to come soon!
0 CommentsComment on Facebook
🌟Thank you to all who attended our #EULAR2025 debrief webinar!
🙌 Especially to our presenters, volunteers & PAN members who shared their insights & experiences.
Stay tuned for more news and updates & don't forget to subscribe to our newsletter! www.lupus-europe.org/emails/
0 CommentsComment on Facebook
